Johns Hopkins Medicine AI Grand Rounds | Elliott R. Haut

Why It Matters

Improving VTE prevention directly saves lives and billions in costs, making rigorous, system‑wide screening a strategic priority for health‑care leaders.

Key Takeaways

• VTE causes up to 100,000 deaths annually, a major public health crisis.
• Guideline adherence for VTE prophylaxis remains low, around 40‑60% across specialties.
• Increased ultrasound screening uncovers more DVTs, illustrating surveillance bias.
• Multi‑disciplinary leadership academy graduates will drive future quality‑improvement projects.
• System‑wide VTE prevention can save billions in healthcare costs annually.

Summary

The Johns Hopkins Medicine AI Grand Rounds featured Dr. Elliott Haut, who highlighted venous thromboembolism (VTE) as a leading preventable cause of hospital death and a public‑health emergency. He celebrated the 15‑year‑old Armstrong Leadership Academy, whose graduating scholars span nurses, physicians, and quality‑improvement leaders across the health system.

Haut presented stark data: VTE affects up to one million Americans yearly, causing roughly 100,000 deaths—more than motor‑vehicle crashes, breast cancer, and AIDS combined. Each event adds $10‑20 k in costs, totaling $10‑20 billion nationally. Yet guideline‑based prophylaxis is applied in only 40‑60 % of cases, a gap that persists despite clear recommendations from multiple specialty societies.

He illustrated surveillance bias with a before‑after study and a large database analysis showing hospitals performing more duplex ultrasounds detect up to seven times more DVTs. A national survey of trauma surgeons revealed split opinions on screening high‑risk asymptomatic patients, underscoring practice variation.

The talk underscored that systematic, evidence‑based VTE screening and prophylaxis can dramatically reduce mortality and expenditures. Graduates of the Leadership Academy are positioned to champion these quality‑improvement initiatives, translating data into hospital‑wide protocols that close the evidence‑practice gap.

Original Description

”May 29, 2026: At the Armstrong Institute Grand Rounds, Elliott R. Haut, M.D., Ph.D. presented evidence-based strategies to reduce venous thromboembolism (VTE), highlighting system-level approaches to improve prophylaxis prescribing and adherence, the impact of surveillance bias on reported VTE rates, and the importance of patient and family engagement in preventing missed prophylaxis doses and improving patient safety.”